Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Creatinine sulfate mixture with serotonin
RN: 971-74-4
UNII: G63220IH3V
InChIKey: WFZKRNIMSVDNBU-UHFFFAOYSA-N

Classification Codes

  • Drug / Therapeutic Agent
  • Mutation Data
  • Protective Agents
  • Radiation-Protective Agents
  • Reproductive Effect

Molecular Formulas

  • C10-H12-N2-O.C4-H7-N3-O.H2-O4-S
  • C10-H12-N2-O.C4-H7-N3-O.H2-O4-S.H2-O
  • C14-H21-N5-O6-S

Molecular Weight

  • 387.4149
 
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Results Name

  • Creatinine sulfate mixture with serotonin

Name of Substance

  • 5-Hydroxytryptamine creatinine sulfate

Synonyms

  • 3-(2-Aminoethyl)indol-5-ol, creatinine sulfate
  • 5-HT creatinine sulfate
  • 5-Hydroxytryptamine creatinine sulfate
  • 5-Hydroxytryptamine creatinine sulfate monohydrate
  • AI3-50935
  • Creatinine sulfate mixture with serotonin
  • Creatinine, sulfate, compd. with 3-(2-aminoethyl)indol-5-ol (1:1:1)
  • Creatinine, sulfate, compd. with 3-(2-aminoethyl)indole-5-ol (1:1:1), monohydrate
  • EINECS 213-539-3
  • NSC 379432
  • NSC 58241
  • Serotonin creatinine sulfate
  • Serotonin creatinine sulfate complex
  • Serotonin creatinine sulfate monohydrate
  • Serotonin-creatinine sulphate
  • UNII-G63220IH3V

Systematic Names

  • 1H-Indol-5-ol, 3-(2-aminoethyl)-, compound with 2-amino-1,5-dihydro-1-methyl-4H-imidazol-4-one sulfate (salt) (1:1)
  • 2-Amino-1,5-dihydro-1-methyl-4H-imidazol-4-one cpd with 3-(2-aminoethyl)-1H-indol-5-ol sulfate
  • 3-(2-Aminoethyl)indol-5-ol 2-imino-1-methylimidazolidin-4-one sulphate (1:1)
  • Indol-5-ol, 3-(2-aminoethyl)-, compd. with creatinine sulfate

Registry Numbers

CAS Registry Number

  • 971-74-4

FDA UNII

  • G63220IH3V

Other Registry Numbers

  • 58823-96-4
  • 64293-99-8
  • 6600-38-0

System Generated Number

  • 0000971744

Molecular Formulas

Molecular Formulas

  • C10-H12-N2-O.C4-H7-N3-O.H2-O4-S
  • C10-H12-N2-O.C4-H7-N3-O.H2-O4-S.H2-O
  • C14-H21-N5-O6-S

Molecular Formula Fragments

  • C10-H12-N2-O
  • C4-H7-N3-O
  • COMPONENT
  • H2-O
  • H2-O4-S

Structure Descriptors

InChI

1S/C10H12N2O.C4H7N3O.H2O4S/c11-4-3-7-6-12-10-2-1-8(13)5-9(7)10;1-7-2-3(8)6-4(7)5;1-5(2,3)4/h1-2,5-6,12-13H,3-4,11H2;2H2,1H3,(H2,5,6,8);(H2,1,2,3,4)

InChIKey

WFZKRNIMSVDNBU-UHFFFAOYSA-N

Smiles

c12c([nH]cc1CC[NH3+])ccc(c2)O.C1[N+](C(=N)NC1=O)C.S(=O)(=O)([O-])[O-]

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
guinea pig LD50 intravenous 28mg/kg (28mg/kg) LUNGS, THORAX, OR RESPIRATION: BRONCHIOLAR CONSTRICTION Journal of Pharmaceutical Sciences. Vol. 57, Pg. 1543, 1968.
mouse LD50 intraperitoneal 405mg/kg (405mg/kg)   Yakugaku Zasshi. Journal of Pharmacy. Vol. 94, Pg. 1620, 1974.
mouse LD50 intravenous 352mg/kg (352mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 105, Pg. 80, 1952.
mouse LD50 subcutaneous > 1997mg/kg (1997mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 105, Pg. 80, 1952.
rat LD50 intravenous 66mg/kg (66mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 105, Pg. 80, 1952.
rat LD50 subcutaneous 257mg/kg (257mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 105, Pg. 80, 1952.